Skip to main content
Premium Trial:

Request an Annual Quote

Marligen Acquires Early-Stage Technology Developer Clarius

NEW YORK, Aug. 12-The DNA analysis supply company Marligen Biosciences said today that it had acquired Clarius Technologies, a company specializing in commercializing intellectual property generated in academic and government research.


Under the agreement, Marligen acquires all assets and rights to Clarius' technology licenses. Clarius' staff and operations, based in Rockville, Md., will be moved to Marligen's facilities.


Marligen, based in Ijamsville, Md., sells a range of DNA purification products, PCR supplies and SNP-related products and services.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more